Global HIV/AIDS Testing Industry

Oct 26, 2011, 06:13 ET from Reportlinker

NEW YORK, Oct. 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global HIV/AIDS Testing Industry

http://www.reportlinker.com/p098402/Global-HIV/AIDS-Testing-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics

This report analyzes the worldwide markets for HIV/AIDS Testing in US$ Million by the following product segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 63 companies including many key and niche players such as Abbott Laboratories Inc., Abbott Molecular Inc., Adaltis S.r.l., Biomérieux SA, Bio-Rad Laboratories Inc., Calypte Biomedical Corporation, Celera Group, Gen-Probe, Inc., Innogenetics NV, MedMira Laboratories, Inc., Medical Services International Inc., OraSure Technologies Inc., Ortho-Clinical Diagnostics Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

HIV/AIDS TESTING MCP-3401

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 2

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

Definitions 3

HIV/AIDS Screening Tests 3

HIV/AIDS Confirmatory Tests 3

HIV/AIDS Monitoring Tests 4

2. INDUSTRY OVERVIEW 5

Recession & Healthcare Industry 5

Impact on Testing Market 5

IVD Market: Growth Despite Recession 5

AIDS Testing, Treatment and Services - An Insight 6

Worldwide HIV/AIDS Testing Market - An Analysis 6

Regional Analysis 7

Segment Analysis 7

HIV/AIDS Screening 7

Confirmatory Test Market 8

HIV/AIDS Monitoring Market 8

Growth Drivers 8

Rapid HIV Tests - Vast Growth Potential 9

New HIV Assays to Fuel Growth 9

Home Testing to Gain Strength 10

Molecular Diagnostics Register Strong Growth in Blood

Screening Markets 10

Ultra-Rapid HIV-screening Tests- A Strong Fight against HIV-

Epidemic 10

Emergency Room Testing to Help HIV Diagnosis 10

OTC HIV Tests to See The Light? 11

Leading Players 11

FDA Approved Rapid Test Kits 12

HIV/AIDs Diagnostics Market Participants - Product Matrix 12

3. AIDS: A GLOBAL EPIDEMIC 14

AIDS - A Serious Threat 14

Facts & Figures 14

Table 1: HIV/AIDS Statistics Worldwide: End-2008 (includes

corresponding Graph/Chart) 15

Table 2: Worldwide Living Population Infected with HIV/AIDS

(2008-End) (includes corresponding Graph/Chart) 15

Table 3: Worldwide HIV & AIDS Incidences (End-2008):

Percentage Share Breakdown of Living and Newly Infected

Cases by Region (includes corresponding Graph/Chart) 16

Table 4: Worldwide Deaths Due to AIDS (2008-End) (includes

corresponding Graph/Chart) 16

Table 5: HIV/AIDS Cases in Adults and Children Worldwide:

Breakdown by Region-End 2008 17

Table 6: HIV Prevalence (%) in Adults (15-49 years) (

includes corresponding Graph/Chart) 17

New HIV Infections in Young People 18

Anti-AIDS Therapeutics: A Blessing in Disguise in Developed

Countries 18

4. UNDERSTANDING THE DISEASE 19

Mechanism of Action 19

Symptoms 20

Full-Blown AIDS 21

Transmission of HIV 22

On the Brighter Side 22

HIV Therapy 22

The Search Continues 23

Infection Process - Targets for HIV Therapy 23

5. DIAGNOSIS OF HIV/AIDS 24

Testing: The Basis for AIDS Prevention and Treatment 24

Blood Processing 24

The Earliest Time to Detect Infection 24

Testing Plagued by Problems Such As 25

Major Drawbacks of Laboratory Diagnosis of HIV Infections 25

Rapid Tests - Suitable for Developing Countries 25

6. HIV TESTS 26

Testing Subject to Strict Rules 26

Diagnostic Tests 26

I. Antibody Tests 26

A. HIV-1 Screening Tests 26

Test Methodology 27

a. Enzyme-linked Immunosorbent Assays/Enzyme Immunoassays

(ELISA/EIA) 27

b. Home AccessHIV-1 test system/Dried Blood Spot 28

c. Rapid Tests 29

Generic Assay Formats in Rapid Test 29

The Dot Blot Rapid Test 29

Agglutination Tests 30

Solid Phase Test 30

Immunochromatographic strip (ICS) Tests 30

Rapid Serological Tests Vs. ELISA Tests 30

B. HIV-1 Antibody Confirmatory Tests 31

a. The Western Blot Test 31

Commonly Used in Developed Countries 31

Interpretation of Results 32

Modified Western Blots 32

b. Indirect Immunofluorescent Antibody Assay (IFA) 32

c. Line Immunoassay 33

d. Radioimmunoprecipitation Assay (RIPA) 33

C. HIV-2 Diagnostic Tests and HIV Group "O 33

Testing Protocols 34

Types of Antibody Tests Based on Sample 34

i. Traditional Blood Antibody Tests 34

ii. Dried Blood Spot (DBS) Sampling Technique 34

Blood Tests Are Highly Expensive 34

iii. Other Alternatives in Samples 35

Oral Testing for HIV 35

Urine Tests 35

II. Viral Identification Assays 35

A. p24 Antigen Test 35

B. Qualitative PCR Tests 36

C. Viral Culture 36

Monitoring Tests 36

A. Lymphocyte Analysis 37

B. Viral Load Tests 37

Indicator of Successful Therapy 38

Levels of CD4 and Viral Load in AIDS 38

C. Drug Resistance Tests 38

Main Types 38

i. Genotyping Tests 39

ii. Phenotyping Tests 39

Molecular Diagnostics and Gene Detection Products 39

DNA Probe-Based Products 39

Direct Assays 39

Amplification 40

Amplification Methodologies 40

7. TECHNOLOGY REVIEW 41

PCR: A Promising Development in HIV/AIDS Monitoring Market 41

DNA Probes are Highly Specific and Sensitive 41

OCA-particles Based Detection System-Offers Increased Accuracy 41

Home HIV Tests: Unfolding a New Era of Testing 41

Yet Nascent 41

Not Without Share of Objections 42

Home Access: Monopolizing the Home HIV Test Kit Market 42

Drawbacks of Blood-Based Tests 42

8. REGULATIONS 43

Overview 43

UN's Testing Policies in Peacekeeping Force 43

Anonymous Versus Confidential Diagnostic Testing for HIV

infection in US 43

Regulatory Approval for Rapid HIV Test Kits in US 43

HIV Testing - Mandatory in US Blood Banks 44

9. NEW PRODUCT APPROVALS & LAUNCHES 45

BioMérieux Launches New HIV Test 45

Quest Diagnostics Releases HIV-1 Coreceptor Tropism Test 45

Avioq Wins FDA Clearance for HIV-1 Microelisa System 46

FDA Approves Ortho Clinical Diagnostics' Diagnostic Assay 46

FDA Approves Abbott's HIV Virus Screening Test 47

10. PRODUCT INTRODUCTIONS/INNOVATIONS IN RECENT PAST -

A PERSPECTIVE BUILDER 48

MedMira Secures Approval for Multiplo Triple Test 48

Calypte Launches Aware Messenger™ 48

Abbott Launches Advanced Viral Load Test 48

MedMira Launches MiraCare™ Rapid Tests with Extended Shelf Life 48

University Researcher Develops Novel HIV/AIDs Antibody Test Kit 49

bioMérieux Introduces VIKIA® HIV 1 / 2 Rapid HIV Test 49

Dr Lal Pathlabs Develops Inexpensive HIV Monitoring Test 49

MedMira to Launch Multiplo™ Rapid HIV/HCV Antibody Test 49

Shanghai Kehua Develops New HIV/AIDS Test Kit for Faster

Diagnosis 49

INSTI™ HIV Test Kit from bioLytical™ Receives European CE Mark 50

Rockeby Biomed Gains Approval from MOH to Sell OraQuick across

Singapore 50

FDA Approves Chembio's Rapid HIV Tests for Sale in the US 50

MiraWell Whole Blood Rapid HIV Test Receives Approval from

China SFDA 50

MiraCare Rapid HIV Antibody Test Receives CE Mark 51

Calypte Receives Approval for Marketing Aware Rapid HIV Tests

in Kenya 51

FDA Approves Bayer's Automated HIV Antibody Test Product 51

SA Government Approves Marketing of Calypte's Aware OMT HIV

Test Product 52

Calypte Introduces OTC Version of Aware HIV Test in UAE 52

Roche Obtains European Union's CE Mark for its cobas TaqScreen

MPX Test 52

11. RECENT INDUSTRY ACTIVITY 53

Spartan Collaborates with Cooperative Diagnostics for PCR

Testing for HIV/AIDS 53

MedMira Inks Private Label Deal with Swiss Partner 53

MedMira Expands Deal with AHD and Forays into Southeast Asian

Markets 54

MedMira Bags Supply Contract from PAHO 54

MedMira Seeks Patent for Latest Rapid Test Platform 54

Abbott Attains Supplemental FDA Approval for RealTime HIV- 1

Viral Load Test 54

USCDC Awards Federal Grant to District of Columbia for HIV

Testing 54

Premier Includes Roche COBAS HIV-1 Monitoring Test in Contract 55

MedMira Receives USAID Approval for Reveal G3 Rapid HIV Test 55

Calypte Biomedical Inks Agreement with Fusion Capital 55

Roche Inks Agreement with Clinton Foundation 56

Ortho-Clinical Attains FDA Approval for HIV Test 56

Geneart Awarded Patent for HIV Vaccine 56

Crucell's Adenovirus Vector Enters Phase I Clinical Studies 56

MedMira to Expand Operations in Eastern Europe 57

Calypte Initiates Sale of Aware™ HIV-1/2 OMT Oral Fluid Test

in India 57

Calypte Receives Approval for Aware HIV-1/2 OMT Test 57

Bundi Opts for SurgiLance Safety Lancet 58

Chembio Diagnostics Receives Sublicense for HIV-2 Patent 58

12. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 59

Calypte Receives USAID Approval 59

Roche's Latest HIV-1 Test Receives FDA Approval 59

OraQuick ADVANCE Becomes Preferred HIV Test kit in Philadelphia 59

Beckman Coulter Receives Grant 59

Oregon Medical Adopts Roche Diagnostics' HIV Test 60

OraSure Inks Agreement with Supply Chain Management System 60

Bio-Rad Enters into Multi-Year Agreements with Quest Diagnostics 60

CytoDyn Pockets Advanced Genetic Technologies 60

Aethlon Partners with ImQuest 61

Quest Diagnostics Receives License from Pathway 61

OraSure Inks Agreement with Constella Group 61

LabCorp to Offer Fully Automated Real-Time HIV Test of Roche

Diagnostics 61

Abbott Receives FDA Approval for RealTime HIV-1 Test 62

Abbott Receives Health Canada Approval 62

Novartis Receives Health Canada Approval 62

Medical Services Completes Trials of VScan Hepatitis C and HIV

Test Kit 62

Health Canada Approves Versant 440 Molecular Systems 62

OraSure Receives CE Mark for OraQuick ADVANCE HIV Test 63

MedMira Receives Approval for Multiplo HBV/HIV/HCV 63

Roche Diagnostics Partners with ARK Diagnostics 63

Roche' HIV Viral Load Test Used In Clinical Trials 63

Innogenetics and Bio-Rad Ink Licensing Agreement 63

OraSure Bags Contract From Madagascar Government 63

Calypte Receives Approval for Aware(TM) HIV-1/2 OMT Rapid Test 64

Siemens Acquires Bayer Diagnostics 64

Gen-Probe's HIV Test Receives FDA Approval 64

Bayer Receives FDA Approval for Automated HIV Test 64

Inverness Receives Marketing Rights for Rapid HIV Test 64

Clinton Foundation Inks Agreement with Guava Technologies 64

MedMira Inks Distribution Agreement with Voden 65

Roche Bags CE Mark certification 65

Chembio Diagnostics Bags Major Contract 65

Calypte Receives Approval for HIV Test 65

Medical Services Expands Distribution Channel in South Africa 65

Rockeby Receives Approval from Singaporean Ministry of Health 66

MedMira Receives SFDA Approval 66

Roche Adopts Primagen's DFS Technology 66

Calypte and Mineseeker to Supply Aware™ AIDS Test Kit Across

Africa 66

OraSure Bags US$6 Million Order to Deliver HIV Test Kits 66

Trinity Biotech Enters into Agreement to Deliver Uni- Gold HIV

Test Kits to PPFA 67

Trinity Biotech Delivers Uni-Gold™ Rapid HIV Test to 340B

Prime Vendor Program 67

MedMira Bags Order from Exportrade for MiraWell Rapid HIV Tests 67

OraSure Receives Bulk Order for Rapid HIV Tests from CDC 68

MedMira Bags Order from Spree Trading for MiraWell Rapid HIV

Tests 68

IRIS Acquires Leucadia with Plans to Introduce HIV & Cancer

Testing Products 68

Clindia to Distribute MiraCare Rapid HIV Test in the Netherlands 68

MedMira Bags Order from Goodman Medical 69

bioMérieux Bags Contract to Provide Equipment for HIV Viral

Load Measurement 69

Novartis Acquires Chiron to Create a New Diagnostics &

Vaccines Division 69

Abbott Enters into Agreement with Novation for Supplying

OraQuick® ADVANCE™ HIV Tests 69

Roche Diagnostics Enters into Three-Year Agreement with

Premier to Deliver Molecular Products 70

MedMira Bags Order to Deliver MiraCare™ HIV Tests Across Europe 70

13. FOCUS ON SELECT GLOBAL PLAYERS 71

Abbott Laboratories, Inc. (USA) 71

Abbott Molecular, Inc. (USA) 71

Adaltis S.r.l. (Italy) 71

Biomérieux SA (France) 71

Bio-Rad Laboratories, Inc. (USA) 72

Calypte Biomedical Corporation (USA) 72

Celera Group (USA) 72

Gen-Probe, Inc. (USA) 73

Innogenetics NV (Belgium) 73

MedMira Laboratories, Inc. (Canada) 73

Medical Services International Inc. (Canada) 74

OraSure Technologies, Inc. (USA) 74

Ortho-Clinical Diagnostics, Inc. (USA) 74

Roche Diagnostics (Switzerland) 75

Siemens Healthcare Diagnostics, Inc. (USA) 75

14. GLOBAL MARKET PERSPECTIVE 76

Unit Analytics 76

Table 7: World Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America, and

Rest of World Markets Independently Analyzed with Annual

Sales Figures in '000 Units for Years 2007 through 2015

(includes corresponding Graph/Chart) 76

Table 8: World Historic Review for HIV/AIDS Testing by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in '000

Units for Years 2000 through 2006 (includes corresponding

Graph/Chart) 77

Table 9: World 11-Year Perspective for HIV/AIDS Testing by

Geographic Region - Percentage Breakdown of Unit Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America, and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 78

Table 10: World Recent Past, Current & Future Analysis for

HIV/AIDS Screening Tests by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America,

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in '000 Units for Years 2007 through 2015

(includes corresponding Graph/Chart) 79

Table 11: World Historic Review for HIV/AIDS Screening Tests

by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America, and Rest of

World Markets Independently Analyzed with Annual Sales

Figures in '000 Units for Years 2000 through 2006 (includes

corresponding Graph/Chart) 80

Table 12: World 11-Year Perspective for HIV/AIDS Screening

Tests by Geographic Region - Percentage Breakdown of Unit

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America, and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 81

Table 13: World Recent Past, Current & Future Analysis for

HIV/AIDS Confirmatory Tests by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America, and Rest of World Markets Independently Analyzed

with Annual Sales Figures in '000 Units for Years 2007

through 2015 (includes corresponding Graph/Chart) 82

Table 14: World Historic Review for HIV/AIDS Confirmatory

Tests by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America, and Rest of

World Markets Independently Analyzed with Annual Sales

Figures in '000 Units for Years 2000 through 2006 (includes

corresponding Graph/Chart) 83

Table 15: World 11-Year Perspective for HIV/AIDS Confirmatory

Tests by Geographic Region - Percentage Breakdown of Unit

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America, and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 84

Dollar Analytics 85

Table 16: World Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America, and

Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 85

Table 17: World Historic Review for HIV/AIDS Testing by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Millions for Years 2000 through 2006 (includes corresponding

Graph/Chart) 86

Table 18: World 11-Year Perspective for HIV/AIDS Testing by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America, and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 87

Table 19: World Recent Past, Current & Future Analysis for

HIV/AIDS Screening Tests by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America &

Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 88

Table 20: World Historic Review for HIV/AIDS Screening Tests

by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America & Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Millions for Years 2000 through 2006 (includes

corresponding Graph/Chart) 89

Table 21: World 11-Year Perspective for HIV/AIDS Screening

Tests by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America, and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 90

Table 22: World Recent Past, Current & Future Analysis for

HIV/AIDS Confirmatory Tests by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America, and Rest of World Markets Independently Analyzed

with Annual Sales Figures in US$ Millions for Years 2007

through 2015 (includes corresponding Graph/Chart) 91

Table 23: World Historic Review for HIV/AIDS Confirmatory

Tests by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America, and Rest of

World Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2000 through 2006 (includes

corresponding Graph/Chart) 92

Table 24: World 11-Year Perspective for HIV/AIDS Confirmatory

Tests by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America, and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 93

Table 25: World Recent Past, Current & Future Analysis for

HIV/AIDS Monitoring Tests by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America,

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 94

Table 26: World Historic Review for HIV/AIDS Monitoring Tests

by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America, and Rest of

World Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2000 through 2006 (includes

corresponding Graph/Chart) 95

Table 27: World 11-Year Perspective for HIV/AIDS Monitoring

Tests by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America, and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 96

15. THE UNITED STATES 97

A.Market Analysis 97

Outlook 97

Rapid HIV Tests Display Rapid Growth 97

FDA Approved Rapid Test Kits 98

NAT Tests Score High in Blood Banks 98

HIV/AIDS Stats 98

Table 28: Percentage of HIV/AIDS Cases in the US, by

Gender: 1993-2029 (includes corresponding Graph/Chart) 99

Table 29: AIDS Diagnoses in the US (2005): Breakdown by

Ethnic Groups/Race (includes corresponding Graph/Chart) 99

Major End-Users of HIV/AIDS Tests 100

HIV Testing Made Mandatory in Blood Banks 100

Home HIV Tests 100

Efforts by Organizations 101

FDA Approved HIV/AIDS Tests in the US Market (2006-2009) 101

FDA Approved HIV/AIDS Tests in the US market (1998-2004) 102

Competitive Structure 104

Historic Market Share Data 105

Table 30: Leading Players in the HIV Diagnostics Market in

the US (2005): Percentage Share Breakdown of Value Sales

for Abbott Laboratories, Bio-Rad, BioMerieux, Ortho

Clinical Diagnostics and Others (includes corresponding

Graph/Chart) 105

Table 31: Leading Players in HIV Viral Load Testing Market

in the US (2005): Percentage Share Breakdown of Value

Sales Roche, Bayer, and Others (includes corresponding

Graph/Chart) 105

B.Market Analytics 106

Table 32: US Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests and HIV/AIDS Confirmatory Tests Markets Independently

Analyzed with Annual Sales Figures in 000' Units for Years

2007 through 2015 (includes corresponding Graph/Chart) 106

Table 33: US Historic Review for HIV/AIDS Testing by Product

Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory

Tests Markets Independently Analyzed with Annual Sales

Figures in 000' Units for Years 2000 through 2006 (includes

corresponding Graph/Chart) 107

Table 34: US 11-Year Perspective for HIV/AIDS Testing by

Product Segment - Percentage Breakdown of Unit Sales for

HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests

Markets for 2005, 2010 & 2015 107

Table 35: US Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment - HIV/AIDS Screening

Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring

Tests Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 108

Table 36: US Historic Review for HIV/AIDS Testing by Product

Segment -HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory

Tests, and HIV/AIDS Monitoring Tests Markets Independently

Analyzed with Annual Sales Figures in US$ Millions for Years

2000 through 2006 (includes corresponding Graph/Chart) 109

Table 37: US 11-Year Perspective for HIV/AIDS Testing by

Product Segment - Percentage Breakdown of Dollar Sales for

HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and

HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 109

16. CANADA 110

A.Market Analysis 110

Outlook 110

AIDS/HIV: Some Facts & Figures 110

Table 38: AIDS Cases in Canada by Ethnic Status: 2002 -

2006 (includes corresponding Graph/Chart) 111

HIV Statistics 111

Table 39: HIV Statistics for Canada by Exposure Category:

2008 (includes corresponding Graph/Chart) 112

Table 40: AIDs and Positive HIV Cases in Canada by Age

Group: 2006-End (includes corresponding Graph/Chart) 113

HIV Incidence Among Women 113

B.Market Analytics 114

Table 41: Canadian Recent Past, Current & Future Analysis

for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests and HIV/AIDS Confirmatory Tests Markets Independently

Analyzed with Annual Sales Figures in 000' Units for Years

2007 through 2015 (includes corresponding Graph/Chart) 114

Table 42: Canadian Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests and HIV/AIDS

Confirmatory Tests Markets Independently Analyzed with

Annual Sales Figures in 000' Units for Years 2000 through

2006 (includes corresponding Graph/Chart) 115

Table 43: Canadian 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Unit Sales for

HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests

Markets for 2005, 2010 & 2015 115

Table 44: Canadian Recent Past, Current & Future Analysis

for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests, HIV/AIDS Confirmatory Tests, and HIV/ AIDS Monitoring

Tests Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 116

Table 45: Canadian Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests, HIV/AIDS

Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets

Independently Analyzed with Annual Sales Figures in US$

Millions for Years 2000 through 2006 (includes corresponding

Graph/Chart) 117

Table 46: Canadian 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Dollar Sales

for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests,

and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 117

17. JAPAN 118

Market Analysis 118

Table 47: Japanese Recent Past, Current & Future Analysis

for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests and HIV/AIDS Confirmatory Tests Markets Independently

Analyzed with Annual Sales Figures in 000' Units for Years

2007 through 2015 (includes corresponding Graph/Chart) 118

Table 48: Japanese Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests and HIV/AIDS

Confirmatory Tests Markets Independently Analyzed with

Annual Sales Figures in 000' Units for Years 2000 through

2006 (includes corresponding Graph/Chart) 119

Table 49: Japanese 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Unit Sales for

HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests

Markets for 2005, 2010 & 2015 119

Table 50: Japanese Recent Past, Current & Future Analysis

for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring

Tests Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 120

Table 51: Japanese Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests, HIV/AIDS

Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets

Independently Analyzed with Annual Sales Figures in US$

Millions for Years 2000 through 2006 (includes corresponding

Graph/Chart) 121

Table 52: Japanese 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Dollar Sales

for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests,

and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 121

18. EUROPE 122

A.Market Analysis 122

Outlook 122

Regional Analysis 122

Segment Analysis 122

AIDs/HIV Stats - A Review 122

Western Europe 123

Table 53: HIV/AIDS Prevalence in Western Europe: Facts and

Figures by Country (2007) (includes corresponding Graph/

Chart) 123

Central Europe 123

Table 54: HIV/AIDS Prevalence in Central Europe: Facts and

Figures by Country (2007) 124

Table 55: HIV Diagnosis in Central Europe: Facts and

Figures by Country(2006) (includes corresponding

Graph/Chart) 124

E astern Europe 125

Table 56: HIV/AIDS Prevalence in Eastern Europe: Facts and

Figures by Country (2007) 125

Table 57: HIV Diagnosis in Eastern Europe: Facts and

Figures by Country (2006) (includes corresponding

Graph/Chart) 126

Regulations 127

Antenatal HIV Testing in Europe 127

Finland 127

Germany 127

Luxembourg 127

Sweden 127

B.Market Analytics 128

Unit Analytics 128

Table 58: European Recent Past, Current & Future Analysis

for HIV/AIDS Testing by Geographic Region - France,

Germany, Italy, UK, Spain, & Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in '000

Units for Years 2007 through 2015 (includes corresponding

Graph/Chart) 128

Table 59: European Historic Review for HIV/AIDS Testing by

Geographic Region - France, Germany, Italy, UK, Spain, &

Rest of Europe Markets Independently Analyzed with Annual

Sales Figures in '000 Units for Years 2000 through 2006

(includes corresponding Graph/Chart) 129

Table 60: European 11-Year Perspective for HIV/AIDS Testing

by Geographic Region - Percentage Breakdown of Unit Sales

for France, Germany, Italy, UK, Spain, and Rest of Europe

Markets for Years 2005, 2010 & 2015 (includes corresponding

Graph/Chart) 130

Table 61: European Recent Past, Current & Future Analysis

for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests and HIV/AIDS Confirmatory Tests Markets Independently

Analyzed with Annual Sales Figures in 000' Units for Years

2007 through 2015 (includes corresponding Graph/Chart) 131

Table 62: European Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests and HIV/AIDS

Confirmatory Tests Markets Independently Analyzed with

Annual Sales Figures in 000' Units for Years 2000 through

2006 (includes corresponding Graph/Chart) 131

Table 63: European 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Unit Sales for

HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests

Markets for 2005, 2010 & 2015 132

Dollar Analytics 133

Table 64: European Recent Past, Current & Future Analysis

for HIV/AIDS Testing by Geographic Region - France,

Germany, Italy, UK, Spain, & Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Millions for Years 2007 through 2015 (includes

corresponding Graph/Chart) 133

Table 65: European Historic Review for HIV/AIDS Testing by

Geographic Region - France, Germany, Italy, UK, Spain, &

Rest of Europe Markets Independently Analyzed with Annual

Sales Figures in US$ Millions for Years 2000 through 2006

(includes corresponding Graph/Chart) 134

Table 66: European 11-Year Perspective for HIV/AIDS Testing

by Geographic Region - Percentage Breakdown of Dollar Sales

for France, Germany, Italy, UK, Spain, & Rest of Europe

Markets for Years 2005, 2010 & 2015 (includes corresponding

Graph/Chart) 135

Table 67: European Recent Past, Current & Future Analysis

for HIV/AIDS Testing by Product Segment - HIV/AIDS

Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS

Monitoring Tests Markets Independently Analyzed with Annual

Sales Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 136

Table 68: European Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests, HIV/AIDS

Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 137

Table 69: European 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Dollar Sales

for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests,

and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 137

18a. FRANCE 138

Market Analysis 138

Table 70: French Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests and HIV/AIDS Confirmatory Tests Markets Independently

Analyzed with Annual Sales Figures in 000' Units for Years

2007 through 2015 (includes corresponding Graph/Chart) 138

Table 71: French Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests and HIV/AIDS

Confirmatory Tests Markets Independently Analyzed with

Annual Sales Figures in 000' Units for Years 2000 through

2006 (includes corresponding Graph/Chart) 139

Table 72: French 11-Year Perspective for HIV/AIDS Testing by

Product Segment - Percentage Breakdown of Unit Sales for

HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests

Markets for 2005, 2010 & 2015 139

Table 73: French Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment - HIV/AIDS Screening

Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring

Tests Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 140

Table 74: French Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests, HIV/AIDS

Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets

Independently Analyzed with Annual Sales Figures in US$

Millions for Years 2000 through 2006 (includes corresponding

Graph/Chart) 141

Table 75: French 11-Year Perspective for HIV/AIDS Testing by

Product Segment - Percentage Breakdown of Dollar Sales for

HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and

HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 141

18b. GERMANY 142

Market Analysis 142

Table 76: German Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests and HIV/AIDS Confirmatory Tests Markets Independently

Analyzed with Annual Sales Figures in 000' Units for Years

2007 through 2015 (includes corresponding Graph/Chart) 142

Table 77: German Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests and HIV/AIDS

Confirmatory Tests Markets Independently Analyzed with

Annual Sales Figures in 000' Units for Years 2000 through

2006 (includes corresponding Graph/Chart) 143

Table 78: German 11-Year Perspective for HIV/AIDS Testing by

Product Segment - Percentage Breakdown of Unit Sales for

HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests

Markets for 2005, 2010 & 2015 143

Table 79: German Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment - HIV/AIDS Screening

Tests, HIV/AIDS Confirmatory Tests, and HIV/ AIDS Monitoring

Tests Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 144

Table 80: German Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests, HIV/AIDS

Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets

Independently Analyzed with Annual Sales Figures in US$

Millions for Years 2000 through 2006 (includes corresponding

Graph/Chart) 145

Table 81: German 11-Year Perspective for HIV/AIDS Testing by

Product Segment - Percentage Breakdown of Dollar Sales for

HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and

HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 145

18c. ITALY 146

A.Market Analysis 146

Outlook 146

Few Facts 146

Table 82: HIV/AIDS Prevalence Rates by Age Group in Italy:

End of 2007 (includes corresponding Graph/Chart) 146

B.Market Analytics 147

Table 83: Italian Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests and HIV/AIDS Confirmatory Tests Markets Independently

Analyzed with Annual Sales Figures in 000' Units for Years

2007 through 2015 (includes corresponding Graph/Chart) 147

Table 84: Italian Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests and HIV/AIDS

Confirmatory Tests Markets Independently Analyzed with

Annual Sales Figures in 000' Units for Years 2000 through

2006 (includes corresponding Graph/Chart) 148

Table 85: Italian 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Unit Sales for

HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests

Markets for 2005, 2010 & 2015 148

Table 86: Italian Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment - HIV/AIDS Screening

Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring

Tests Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 149

Table 87: Italian Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests, HIV/AIDS

Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets

Independently Analyzed with Annual Sales Figures in US$

Millions for Years 2000 through 2006 (includes corresponding

Graph/Chart) 150

Table 88: Italian 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Dollar Sales

for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests,

and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 150

18d. THE UNITED KINGDOM 151

A.Market Analysis 151

Outlook 151

Trends in HIV and AIDS Statistics 151

Table 89: HIV Diagnoses in the UK by Exposure Category:

1995 Till June 2007 (includes corresponding Graph/Chart) 152

Table 90: HIV Cases in the UK: Breakdown by Age Group Till

June 2009 (includes corresponding Graph/Chart) 152

B.Market Analytics 153

Table 91: UK Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests and HIV/AIDS Confirmatory Tests Markets Independently

Analyzed with Annual Sales Figures in 000' Units for Years

2007 through 2015 (includes corresponding Graph/Chart) 153

Table 92: UK Historic Review for HIV/AIDS Testing by Product

Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory

Tests Markets Independently Analyzed with Annual Sales

Figures in 000' Units for Years 2000 through 2006 (includes

corresponding Graph/Chart) 154

Table 93: UK 11-Year Perspective for HIV/AIDS Testing by

Product Segment - Percentage Breakdown of Unit Sales for

HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests

Markets for 2005, 2010 & 2015 154

Table 94: UK Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment - HIV/AIDS Screening

Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring

Tests Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 155

Table 95: UK Historic Review for HIV/AIDS Testing by Product

Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory

Tests, and HIV/AIDS Monitoring Tests Markets Independently

Analyzed with Annual Sales Figures in US$ Millions for Years

2000 through 2006 (includes corresponding Graph/Chart) 156

Table 96: UK 11-Year Perspective for HIV/AIDS Testing by

Product Segment - Percentage Breakdown of Dollar Sales for

HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and

HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 156

18e. SPAIN 157

Market Analysis 157

Table 97: Spanish Recent Past, Current & Future Analysis for

HIV/AIDS Testing by Product Segment -HIV/AIDS Screening

Tests and HIV/AIDS Confirmatory Tests Markets Independently

Analyzed with Annual Sales Figures in 000' Units for Years

2007 through 2015 (includes corresponding Graph/Chart) 157

Table 98: Spanish Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests and HIV/AIDS

Confirmatory Tests Markets Independently Analyzed with

Annual Sales Figures in 000' Units for Years 2000 through

2006 (includes corresponding Graph/Chart) 158

Table 99: Spanish 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Unit Sales for

HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests

Markets for 2005, 2010 & 2015 158

Table 100: Spanish Recent Past, Current & Future Analysis

for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening

Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring

Tests Markets Independently Analyzed with Annual Sales

Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 159

Table 101: Spanish Historic Review for HIV/AIDS Testing by

Product Segment -HIV/AIDS Screening Tests, HIV/AIDS

Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets

Independently Analyzed with Annual Sales Figures in US$

Millions for Years 2000 through 2006 (includes corresponding

Graph/Chart) 160

Table 102: Spanish 11-Year Perspective for HIV/AIDS Testing

by Product Segment - Percentage Breakdown of Dollar Sales

for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests,

and HIV/AIDS Monitoring Tests Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 160

18f. REST OF EUROPE 161

A.Market Analysis 161

Outlook 161

AIDS Review 161

Austria 161

Russia 162

Ukraine 162

Other European Countries 162

B.Market Analytics 163

Table 103: Rest of Europe Recent Past, Current & Future

Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS

Screening Tests and HIV/AIDS Confirmatory Tests Markets

Independently Analyzed with Annual Sales Figures in '000

Units for Years 2007 through 2015 (includes corresponding

Graph/Chart) 163

Table 104: Rest of Europe Historic Review for HIV/AIDS

Testing by Product Segment - HIV/AIDS Screening Tests and

HIV/AIDS Confirmatory Tests Markets Independently Analyzed

with Annual Sales Figures in 000' Units for Years 2000

through 2006 (includes corresponding Graph/Chart) 164

Table 105: Rest of Europe 11-Year Perspective for HIV/AIDS

Testing by Product Segment - Percentage Breakdown of Unit

Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory

Tests Markets for 2005, 2010 & 2015 164

Table 106: Rest of Europe Recent Past, Current & Future

Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS

Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS

Monitoring Tests Markets Independently Analyzed with Annual

Sales Figures in US$ Millions for Years 2007 through 2015

(includes corresponding Graph/Chart) 165

Table 107: Rest of Europe Historic Review for HIV/AIDS

Testing by Product Segment -HIV/AIDS Screening Tests,

HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests

Markets Independently Analyzed with Annual Sales Figures in

US$ Millions for Years 2000 through 2006 (includes

corresponding Graph/Chart) 166

Table 108: Rest of Europe 11-Year Perspective for HIV/AIDS

Testing by Product Segment - Percentage Breakdown of Dollar

Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory

Tests, HIV/AIDS Monitoring Tests Markets for 2005, 2010 &

2

To order this report:

Diagnostics Industry: Global HIV/AIDS Testing Industry

More  Market Research Report

Check our  Real Time Industry Data

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com